Transatel Adopts Oracle Cloud Native 5G Signaling Core to Power Next-Gen IoT Connectivity

Comparamos o AWS, Oracle Cloud (OCI) e Nextcloud para auxiliar na escolha entre nuvem pública e infraestrutura própria, visando decisões estratégicas para seu negócio ou carreira.

Larry Ellison’s software company falls more than rivals over its borrowing and reliance on OpenAI contracts

Specialized ERP systems designed for the pharmaceutical industry offer tailored features that outperform generic alternatives, leading to shorter implementation times and increased success rates. Despite vendor claims of flexibility, relying on ad-hoc arrangements can result in unforeseen challenges. The pre-baked capabilities within the system's data model play a crucial role in preventing issues with version upgrades, ensuring a smooth and streamlined implementation process. Opting for ERP systems with pre-built pharma capabilities, such as the ability to manage multiple serial and lot numbers, is essential for the pharmaceutical industry. These features, often lacking in smaller ERP systems designed for single serial or lot numbers, are critical for addressing the intricacies of pharmaceutical manufacturing and distribution. While pharma-specific ERP systems excel in providing deeper last-mile capabilities, their focus may be limited to a few specific business models. This limitation can pose scalability challenges for larger pharmaceutical companies experiencing growth or engaging in acquisition phases. Predicting future needs becomes complex, especially for companies involved in M&A cycles, owned by private equity, or part of a holding company structure. Larger ERP solutions may support various models, but implementing compliance-specific features can be costly. On the other hand, smaller systems might encounter limitations in global applications due to flatter architecture, underscoring the importance of carefully evaluating the scalability and flexibility of ERP systems tailored for the pharmaceutical industry. Technical expertise alone is insufficient when it comes to pharma-specific compliance; a deeper subject matter expertise is essential. This includes capturing National Drug Code (NDC) codes, managing both serial and lot numbers for the same product, and handling inventory based on expiring lots. Addressing data structure nuances is one challenge, but meeting aggressive traceability demands and Drug Supply Chain Security Act (DSCSA) compliance adds another layer of complexity. Evaluating ERP systems for pharmaceutical needs is facilitated by exploring the top 10 pharma ERP systems, offering valuable insights into the solutions that best address the unique challenges and requirements of the pharmaceutical industry. ------------------------------- Resources and Links Read More: Download our 2024 digital transformation report: https://www.elevatiq.com/guides-and-reports/digital-transformation-trends-report/ Download the ERP Selection Guide: https://www.elevatiq.com/guides-and-reports/erp-selection-guide/ Download our ERP Selection Requirements Matrix: https://www.elevatiq.com/resources/ERP-Requirements-Template/ Download ERP Systems Scorecard Sheet: https://www.elevatiq.com/resources/ERP-Systems-Scorecard-Sheet/ Insights on ElevatIQ: https://www.elevatiq.com/blog/ WBSRocks Podcast: https://podcast.wbs.rocks/ ------------------------------------- If you have any questions or comments about how to navigate the complex ERP system, don’t hesitate to leave a comment on this video or drop us a line at hello@elevatiq.com. ------------------------------- Find me: LinkedIn: https://www.linkedin.com/in/samguptausa/ Twitter: https://twitter.com/samguptausa Listen and subscribe: 🎧 Apple: http://ow.ly/UHT950HKrf8 🎧 Spotify: http://ow.ly/1vYw50HKrf0 🎧 Google: http://ow.ly/JMBG50HKrf7 ------------------------------------- #ERP #DigitalTransformation #pharma

Learn about the top 10 eCommerce platforms in 2025 and how they differ in their capabilities including their strengths and weaknesses.